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Dendrimers and telodendrimer micelles represent two new classes of vehicles for drug delivery that have attracted much attention
recently. Their structural characterization at the molecular and submolecular level remains a challenge due to the diﬃculties in
reaching high resolution when imagingsmall particles in their native media. This investigation oﬀe r san e wa p p r o a c ht o w a r d st h i s
challenge, using scanning tunneling microscopy (STM) and atomic force microscopy (AFM). By using new sample preparation
protocols, this work demonstrates that (a) intramolecular features such as drug molecules and dendrimer termini can be resolved;
and (b) telodendrimer micelles can be immobilized on the surface without compromising structural integrity, and as such, high
resolutionAFM imagingmaybe performed to attain3Dinformation.This high-resolutionstructural informationshouldenhance
our knowledge of the nanocarrier structure and nanocarrier-drug interaction and, therefore, facilitate design and optimization of
the eﬃciency in drug delivery.
1.Introduction
Using nanoparticles composed of polymers or assemblies
of amphiphilic molecules as drug delivery vehicles have
attracted much attention in the recent quest for drug
delivery [1–3]. Among them, many dendrimers have been
synthesized with a great degree of control in the synthesis
of the designed structure [4, 5]. Dendrimers exhibit great
promise as nanocarriers for eﬃcient drug delivery due to
researchers’ abilitytocontroltheir size (e.g.,1nm to100nm)
through the variation of iteration cycles and to implement
surface and intramolecular functionalities designed to carry
or trap desired drug molecules through covalent, hydropho-
bic, ionic, or hydrogen-bonding interactions [1, 6–9]. Suc-
cessful examples have been reported, such as the increase
in solubility and in vivo compatibility of non-steroidal
anti-inﬂammatory drugs (NSAIDs) using functionalized
dendrimer carriers [10–14]. Speciﬁcally, the combination
of indomethacin with poly(amidoamine) (PAMAM) dend-
rimers resulted in enhanced in vivo pharmacokinetic perfor-
mance over indomethacin alone [15].
Complimentary to the “hard” dendrimers discussed
above, “soft” nanostructures, such as nanomicelles, made by
assembly of biocompatible telodendrimers (e.g., a linear
poly(ethylene glycol)- (PEG-) block-dendritic oligomers of
cholic acid (CA)) in aqueous conditions were also developed
recently [16–21]. These nanomicelles are highly ﬂexible, and
as such, they exhibit the advantage for in vivo movement.
Since polymer molecules are the basic unit within micelles,
multifunctionalities may be implemented for individual
molecules, and size may be tuned (e.g., d = 15–300nm)
by varying the conditions of assembly. The amphiphilicity
enables the incorporation of hydrophobic drugs such pacli-
taxel (PTX) enclosed inside the micelles, with a load capacity
as high as 7.3mg/mL [16]. The in vitro anticancer activity
of PTX loaded PEG5k-CA8 micelles have been performed2 Journal of Drug Delivery
on human ovarian clear cell carcinoma cells (ES-2) and
ﬁreﬂy luciferase-expressing ovarian adenocarcinoma cell
lines (SKOV3-luc-D3). PTX-loaded PEG5k-CA8 micelles
exhibitedequivalentcytotoxicactivityinvitrocomparedwith
theclinicalformulationsofPTX, such as Taxol and Abraxane
[17]. In vivo antitumor eﬃcacy of PTX loaded PEG5k-CA8
micelles have been tested in nude mice bearing human
SKOV3-lue ovarian cancer xenograft, where the results
indicated that this vehicle could deliver PTX preferentially to
tumor sites via enhanced permeation and retention (EPR)
eﬀect, and thus exhibits superior in vivo anticancer eﬀect
overall in animal models, compared to Taxol and Abraxane
[16, 17].
To enhance the eﬃciency of drug delivery, knowledge of
the nanocarrier structure and nanocarrier-drug interaction
is critical for their design and optimization. In the case of
dendrimer systems, the location and the binding of drug
molecules to dendrimers are particularly important, as the
outcome is directly related to loading capacity and release
behavior. While macroscopic information such as solubility
[12–14]a n ds p e c t r o s c o p y[ 22] are available, little is known
at the molecular level. Despite the prediction by molecular
dynamics simulations [23–25] that drug molecules may
attach to both the exterior and interior of dendrimers,
the direct evidence from experiments is still lacking due
to diﬃculties in visualizing intramolecular structures of
dendrimers. Scanning tunneling microscopy (STM), due to
its high spatial resolution, oﬀers a promising solution to
this challenge [26]. The highest spatial resolution is typically
reported for conductive and semiconductive systems, reach-
ing the submolecular level [27]. Using metal ion coordina-
tion [28, 29], we extended the high-resolution capability of
STMtodendrimersinthisinvestigation, resolving individual
indomethacin molecules at the dendrimer exterior.
In the case oftelodendrimer micelles, dynamic light scat-
tering (DLS) allows the average diameter and distribution
to be determined in the solution phase [16, 17]. Individual
micelles may be visualized using cryotransmission electron
microscopy (cryo-TEM) upon freezing of the samples. The
use of cryo-TEM is complicated, as the micelles are no
longer in their natural environment [30]. A much simpler
technique,atomicforcemicroscopy(AFM),couldoﬀersome
remedy to this pursuit. AFM oﬀers high spatial resolution
andversatilityofimaginginvarious media,includingmicelle
formation media and physiological buﬀers [31–33].
In this study, we have tested the feasibility and demon-
strated the proof-of-concept of using scanning probe micro-
scopy to image PTX-loaded thiol modiﬁed telodendrimer
micelles, HS-PEG5k-CA8 (“5k”, represents the molecular
weight of PEG, and “8” indicates the number of CA subunits
in the telodendrimer), in aqueous media where micelles
form. The results are very encouraging: individual micelles
are clearly visualized, from which we can extract the size and
geometry of micelles in correlation with the conditions of
assembly. The diﬀerence between native and drug carrying
micelles is clearly visible under AFM, from which the drug
carrying capacity can be estimated. In addition, the knowl-
edgeofthegeometryandsizeofindividualmicellesfacilitates
our understanding oftheir eﬃcacy andfurther optimization.
2.Materialsand Methods
2.1. Materials. Paclitaxel was purchased from AK scientiﬁc
Inc. 4th generation hydroxyl-terminated poly(amidoamine)
dendrimers, G4PAMAM-OH (98%purity,10% byweightin
methanol), and 1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-
3-indoleacetic acid, commonly known as indomethacin
(≥99.0%), were purchased from Sigma-Aldrich and used
without further puriﬁcation. 1-adamantanethiol (AD, 95%
purity) and n-octanethiol (C8, 98% purity) were purchased
from Sigma-Aldrich and used as received. 200 proof ethanol
(99.99% purity) was purchased from Gold Shield Chemical
Co. K2PtCl4 (min. 42.4% Pt, Alfa Aesar) was used as
received. Ultrapure water (≥8MΩ·cm) was obtained using a
Millipore Milli-Q ﬁltrationsystem. UltrapureN2 (≥98%,Air
Gas Co.) and H2 (99.99%,Praxair, Inc.) were used for drying
and ﬂaming, respectively. STM tips were made from W wire
(d = 0.010 in, 99.95%, California Fine Wire Co.). Epoxy glue
(Epo-tek 377) was purchased from Epoxy Technology.
2.2. Synthesis of Thiol Functionalized Telodendrimer HS-
PEG5k-CA8. BocNH-PEG5k-CA8 was synthesized following
the established procedure [16]. The Boc protecting group
was removed via the treatment with 50% of triﬂuoroacetic
acid (TFA) in dichloromethane (DCM) for 30min, and
then, the majority of solvent was removed by blowing
nitrogen. The polymer was precipitated by washing three
times with cold ether. S-Trityl-beta-mercaptopropionic acid
(2 equ.) was coupled on the amino groups on the terminal
end of telodendrimer using hydroxybenzotriazole (HOBt, 2
equ.) and diisopropylcarbodiimide (DIC, equ.) as coupling
reagents overnight. The telodendrimer was precipitated and
washed by cold ether and was treated with 50% TFA in
DCM for 30min, then the majority of solvent was removed
by blowing nitrogen. The telodendrimer was precipitated
and washed by cold ether and dissolved in water. The
telodendrimersolutionwasﬁltered andthendialyzed against
4L water in a dialysis tube with molecular weight cut-
oﬀ (MWCO) of 3.5KDa; reservoir water was refreshed
completely four times in 24h. Finally, the telodendrimer was
lyophilized. The molecular weight of the telodendrimer was
detected by matrix-assisted laser desorption ionization—
time of ﬂight mass spectrometry (MALDI-TOF MS) and
nuclear magnetic resonance (NMR) spectrometry. The thiol
group was detected by Ellman’s assay. The synthesized HS-
PEG5k-CA8 telodendrimerwaskeptindesiccatorsbeforeuse.
2.3. Preparation of Gold Thin Films. Au(111) thin ﬁlms were
prepared via thermal evaporation of Au onto freshly cleaved
mica (0001) in a high-vacuum evaporator(Denton Vacuum,
Model 502-A) [34]. The substrate mica was heated via two
quartzlampsto350◦C under a base pressure of 2 × 10−7 torr.
The evaporation rate was 0.3nm/sec and the ﬁnal thickness
of Au ﬁlms was 150nm. After evaporation, the Au was
thermallyannealed insituat375◦Cfor30–60mintoincrease
the size of the Au(111) terraces. After annealing, the Au ﬁlm
was allowed to coolfor ≥5hr. undervacuum.Uponremoval,
the Au ﬁlms were stored in a sealed glass container.Journal of Drug Delivery 3
2.4. Preparation of 1-Adamantanethiol Self-Assembled Mono-
layers (SAMs). The gold ﬁlms described above were used to
prepare ultraﬂat gold ﬁlms on glass substrates following a
method reported previously [35]. Brieﬂy, the gold ﬁlms were
annealed in an H2 ﬂame in order to coalesce the gold grains
on the mica. Then, the gold thin ﬁlm was cooled in air to
roomtemperature.Asmall dropletofepoxygluewas applied
to each of the dry glass substrates (coverslips). The coverslips
were then placed on the gold substrate with the glue
attached side facing down. The glue was then cured at 150◦C
overnight. After removal from oven, the glass coverslip with
gold thin ﬁlm were peeled oﬀ from the mica substrate. The
1-adamantanethiol (AD)SAMs were prepared by immersing
the gold ﬁlms in a 10mM ethanolic AD solution at room
temperature for 24 hours [36]. The AD SAM on gold was
rinsed ﬁrst with ethanol, and then with Milli Q water, before
the deposition of the loaded or unloaded micelles.
2.5. Loading of PTX into HS-PEG5k-CA8 Micelles and Charac-
terization. 6mgofPTXand20mgofHS-PEG 5k-CA8 were
dissolved in 3mL of chloroform in a 10mL single neck
ﬂask to form a homogeneous solution. The solvent was
removed by rotavaporation, and the sample was further
dried on high vacuum pump for 30min. Then, 1mL of
phosphate buﬀered saline (PBS) was added into the ﬂask
to disperse the solid ﬁlm via vortex and further sonication
for 30min to yield a homogenous micelle solution. The
particle sizes of the micelles before and after PTX loading
were measured with DLS Zetatrac (Microtrac) to be 16nm
and 23nm, respectively. The drug loading capacity was
measured using high-performance liquid chromatography
(HPLC) calibrated with PTX solutions in dimethyl sulfoxide
(DMSO) with known concentrations.
2.6. AFM Imaging. A F Mm e a s u r e m e n t so fm i c e l l e sa n d
dendrimers were performed on a MFP3D AFM (Asylum
Research Inc., Santa Barbara, Calif, USA). When imaging
HS-PEG5k-CA8 and PTX-loaded HS-PEG5k-CA8 micelles in
SAMs, tapping mode was utilized in aqueous solution. The
probe is a MSNL-10 silicon cantilever (Veeco, Camarillo,
Calif, USA) with a force constant of k = 0.1 N/m. During
AFM tapping, the cantilever was modulated by a driving
frequency of 68kHz and an amplitude range from 0.30
to 0.71V, with damping from 30 to 70%. When imaging
PAMAM dendrimers, a silicon cantilever (AC-240, Olym-
pus) was used. The probe has a force constant of k =
1.0N/m as measured by thermal noise method. During
tapping mode imaging, the cantilever was modulated by
a driving frequency of 74kHz and amplitude of 67.0nm
(0.63V), with the damping set to 85%. For displacing
adsorbates such as dendrimers or alkanethiolates, tips were
placed in contact with the surface with increasing load
beyond threshold [28, 29]. Data display and analysis were
conducted using MFP-3D’s software package written on Igor
Pro platform (Wavemetrics). The surface coverage of micelle
was calculated based on AFM topography images.
2.7. STM Imaging. The STM has a walker-type scanner
(UHV 300, RHK Technologies, Inc.) and was used under
ambient conditions for this investigation. The STM tips were
cut W wires which were electrochemically etched at 2.0V in
3.0MNaOHsolutions.Ahomemadepotentiostatmonitored
the etching process [34, 37]. All STM images were acquired
in constant current mode with typical bias voltages ranging
from 0.3 to 0.7V and tunneling currents from 5 to 25pA.
The piezoelectric scanners were calibrated laterally using a
decanethiol SAM (lattice constant = 0.50nm) and vertically
using a Au(111) single atomic step (0.235nm).
3.Resultsand Discussion
3.1. Immobilization of Telodendrimer Micelles into SAMs
for AFM Imaging. For structural characterization via AFM,
micelles must be immobilized on surface supports. Immo-
bilized drug delivery vehicles are the key component in
therapies using patches [38]. A potential application of
immobilized PTX-loaded micelleson surfaces isthedevelop-
ment of a new type of PTX eluting stent [39]. The procedure
of immobilization of micelles onto gold surfaces is shown in
Scheme 1.H S - P E G 5k-CA8 telodendrimer is soluble in water
and self-assembles into micelles. PTX is loaded into the
micelle via a procedure of solvent evaporation followed by
the aqueous dispersion of micelles [40].
Inordertomaintaintheintegrityofmicellesonsolidsur-
face, gold surfaces were covered by SAMs of AD. The use of
ADis based mainly on two considerations: (a)SAMs provide
ab u ﬀer to dampen collisions and allow full contact between
micelles and gold surfaces and (b) AD can be exchanged by
alkane thiol functionalities to enable micelles to anchor onto
gold surfaces. Asillustrated in Scheme 1, micelles are formed
instantly via the self-assembly of telodendrimers dissolved
in aqueous solution. The critical micelle concentration of
micelles was 5.3μM. The micelles have noncharged surfaces,
the Zeta-potential was measured close to zero [21]. AD
SAMs on gold were soaked in micelle solutions, 0.5mg/mL,
for 20min. This short exposure resulted in 15.3% surface
coverage of micelles on the gold surface. In the case of PTX-
loadedmicelles, a concentrationof26.4mg/mL(weight ratio
as 6.4mg PTX: 20mg HS-PEG 5k-CA8) was used and the
exposure time was typically 1 hour. This led to 29.0%surface
coverage of PTX loaded micelle on the gold surface. After
deposition, the samples were rinsed with Milli Q water and
kept in the water solution before AFM measurement.
3.2. AFM Enables Visualization Telodendrimer Micelles in
their Native Media and Detection of Changes upon Uptake
of PTX. Upon immobilization, AFM imaging is carried out
in water media. To attain accurate measurements in 3D
without signiﬁcant deformation, tapping mode is utilized,
from which height is extracted from topographic images,
and lateral boundaries are well deﬁned from phase images.
The AFM images in Figure 1 indicate that all micelles, PTX-
loaded or unloaded, maintain the geometry of elliptical cap
geometry. Figure 1(a) is a 300 × 300nm2 AFM topography
image of PTX-loaded micelles on ultraﬂat Au. Each bright
protrusion is a single PTX-loaded micelle. The height of a
typical PTX-loaded micelle, as shown in cursor 1, is 4.0nm,4 Journal of Drug Delivery
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Figure 1: AFM characterization of paclitaxel- (PTX-) loaded HS-PEG5k-CA8 micelles and unloaded HS-PEG5k-CA8 micelle on gold
substrate in aqueous solution. The ﬁrst column is AFM topography (a), phase image (b) and corresponding cursors of PTX-loaded micelle.
AFM topography (c), phaseimage(d), and corresponding cursors of unloaded micelle are shownin second column.In cursor proﬁles,areas
indicated with red, blue, and grey are relative to PTX-loaded micelle, unloaded micelle and AD SAM, respectively. Height, short axis, and
long axis of PTX-loaded micelle extracted from cursors proﬁles 1, 2, and 3. Height, short axis, and long axis of unloaded micelle extracted
from cursors proﬁles 4, 5, and 6.6 Journal of Drug Delivery
measured from the lowest point in the local surroundings
to the apex of the micelle. Its lateral boundaries are clearly
visible from the AFM phase image shown in Figure 1(c).
The lateral dimensions are 28.1nm and 33.0nm for short
axis and long axis, respectively, as shown in cursors 2 and 3.
Among the 49 PTX-loaded micelles measured, the average
3D dimensions (long axis “a”, short axis “b”, and height
“h”) are 31.8 ± 4.3nm, 25.6 ± 3.2nm, and 4.6 ± 0.7nm,
respectively.Asacomparison,Figure 1(b)isa300 ×300nm2
AFM topography image of original micelles on ultraﬂat Au.
The measured height of the unloaded micelle is 1.9nm,
as shown in cursor 4. Figure 1(d) is the phase image of
unloaded micelle, from which the lateral boundaries are
clearly visible. The short and long axis of the unloaded
micelle is 17.3nm and 25.2nm, respectively, as shown in
cursors 5 and 6. Among the 50 unloaded micelles measured,
thea,b,a n dhmeasure 23.7 ± 2.4nm, 17.2 ± 2.3nm, and 1.8
± 0.2nm, respectively.
The volume, V, of each micelle can be calculated using
thesimplegeometricformula:V = (1/6πh)(3/4ab+h2)[ 28].
From Figures 1(a) and 1(c), the height of PTX-loaded
micelleis4.0nm,thelateraldimensionsarea = 33.0nm,b =
28.1nm,thusV = 1490.1nm 3.F r o mF i g u r e s1(b) and 1(d),
the unloaded micelle, measures a = 25.2nm,b = 17.3nm,
and h = 1.9nm, which corresponds to V = 328.9nm 3.T h e
average volume of PTX-loaded micelle and unloaded micelle
is 1475.8 ± 396.2nm3 and 295.1 ± 62.6nm3, respectively.
PTX-loaded micelle exhibits a larger volume than unloaded
micelle. Our Investigations also reveal that the amounts of
PTX uptake aﬀect the volume of micelles.
By assuming that the micelle has a spherical shape in
water solution, we can estimate the diameter of micelles in
solutionbased on V = 4/3π(D/2)
3. Here, V is volumeand D
is the diameter. The volume of a typical PTX-loaded micelle
in Figure 1(a) is 1490.1 nm3, the corresponding diameter
is 14.2nm. Among the 49 PTX-loaded micelles measured,
the average diameter is 14.2 ± 1.2nm. The volume of a
typical unloaded micelle in Figure 1(b) is 328.9nm3,t h e
corresponding diameter is 8.6nm. Among the 50 unloaded
micelles measured, the average diameter is 8.2 ± 0.6nm.
The diameter of PTX-loaded and unloaded micelle obtained
from the dynamic light scatting (DLS) measurement is
23 ± 8a n d1 6± 4nm, respectively [16]. One notes that
the size of adsorbed micelles as determined from AFM
experiments is smaller than the corresponding diameter
measured from the DLS in solution. While DLS gives the
averaged hydrodynamic radius of the scattering particles,
AFM provides true 3D measurements of individual micelle.
The dimensions extracted from AFM measurements more
truly reﬂect the true geometry of the micelles, In addition, it
is diﬃcult to reach high accuracy if the particle is very small
and nonspherical, for example, <10nm [41], while AFM
does not have such a limitation.
As a bonus, we can estimate the number of PTX mol-
ecules based on the volume measurements from AFM. The
numbers of PTX (Nptx) and telodendrimers (Ntelo)a r ee s t i -
mated from two equations below, (a) assuming that the
volume of individual components are conserved, based on
Connolly solvent-excluded volume [42]u s i n gC h e m 3 D
Software, using telodendrimer volume of 13.13nm3,a n d
PTX being 0.754nm3; (b) the mixing follows 7.5: 2.1 = PTX:
telodendrimers. Therefore, for a typical PTX loaded micelle
in Figure 1(a), the volume is 1490.1nm3
Nptx
Ntelo
=
7.5
2.1
,( 1 )
Nptx × 0.754+Ntelo × 13.13 = 1490.1. (2)
Solving (2)w i t h( 1), Nptx = 336, while Ntelo = 94.
For a typical micelle indicated in Figure 1(b), there are 25
telodendrimer units. Within a typical PTX-loaded micelle
as shown in Figure 1(a), there are 336 PTX molecules
and 94 telodendrimers. The increase in overall size upon
PTX loading is likely due to the increase in the number
of the telodendrimer molecules within individual micelles.
The hydrophobicity of PTX may require larger number of
amphiphilic telodendrimers to enclose them inside micelles
for overall reduced enthalpy [43].
Takencollectively,AFMprovidesanalternative andmore
accurate approach to measure the geometry and size of
individual drug delivery vehicles. Even for soft systems such
as HS-PEG5k-CA8 micelles, AFM images may be attained
in their native media. This versatility of imaging in water
media at a designed temperature allows direct comparison
before and after loading or uptake of drugs. In addition, the
accuracy enables quantiﬁcation, such as the determination
of height, lateral dimension, volume, and number of drugs
enclosed. Therefore, we encourage researchers to consider
the application of AFM in determination of the size and
geometry of drug-carrying vehicles in the various synthetic
and drug-loading steps.
3.3. Preparation and Immobilization of PAMAM Dendrimers
for High-Resolution Imaging. To visualize intramolecular
structure of PAMAM dendrimers using STM, two key steps
are involved, surface immobilization and introduction of
metal ions to enable the transport of STM current [28].
Detailed protocols for dendrimers have been discussed
previously [28, 29]. For indomethacin carrying dendrimers,
ﬁrst, G4 PAMAM-OH dendrimer solutions were made by
diluting aliquots of the methanol-based stock solutions
to 12.5μM aqueous solutions. Second, as illustrated in
Scheme 2,K 2PtCl4 was then added to achieve a molar ratio
of 1:120, dendrimer: Pt2+. The ratios were guided by the
numberoftertiary amines (dendrimerbranchpoints)within
individual dendrimers, for example; G4 has 62 tertiary
amines. Once mixed, the solution was kept at room temper-
ature for 3–5 days, allowing suﬃcient time for Pt(II)-amine
coordination within dendrimers [44]. Third, indomethacin
was weighed and then directly added to reach a ﬁnal sto-
ichiometry of 1:120 dendrimer:indomethacin molar ratio
to maximize the potential for interaction between the drug
and the dendrimer −OH termini and available tertiary
amines. Final dendrimer is represented by G4 PAMAM-
OH-(Pt2+)n-(Indo)m, as represented in Scheme 2(c). TheJournal of Drug Delivery 7
G4 PAMAM-OH G4 PAMAM-OH-(Pt+2)n
Pt2+ Indo.
G4 PAMAM-OH-(Pt2+)n-(Indo)m
(a) Surface immobilization
(b) C8 ﬂood ( )
(a) (b) (c)
(d)
Au (111)
Scheme 2: Methodology for the metal ion coordination, drug loading, surface immobilization, and passivation of G4 PAMAM-OH
dendrimers. Dendrimers in solution (a) are doped with Pt2+ ions (b). Indomethacin is then added to the solution (c). The conductive,
drug-loaded dendrimers are then exposed to Au(111) (a) followed by C8 ﬂooding, (b), to obtain the surface-immobilized G4 PAMAM-OH-
(Pt
2+)n-(Indo)m.
indomethacin-dendrimer mixture was vortexed for 30 min.
and allowed to gestate for an additional 2-3 days [10].
For the surface deposition of dendrimers, as shown in
Scheme 2(d),1cm2 pieces ofgold ﬁlms were H2-ﬂamed [34]
and allowed 20min cooling under clean ambient conditions.
Then, a ∼75.0μL drop of G4 PAMAM-OH-(Pt2+)n-(Indo)m
dendrimer solution was deposited onto the Au(111) surface
and allowed to contact for 1.25min. After washing with
water and ethanol the surface was ﬂooded with a 1.0mM C8
solution for 2min. The surface was then washed again with
ethanol and dried under N2 b e f o r eS T Ma n dA F Mi m a g i n g .
The formation of C8 SAMs conﬁnes dendrimers laterally,
thusmaintaining thestructuralintegrity, andpreventslateral
movement during scanning [28]. SAMs also serves as an
important internal reference standard for lateral calibration.
3.4. Combined AFM and STM Investigations Enable the Size
and Geometry of Individual Dendrimers to be Determined.
While STM enables high-resolution imaging and accurate
determination of the lateral dimension of individual den-
drimers [28], AFM allows for the height to be measured
precisely [28, 45, 46]. Scheme 3 illustrates this combined
approach. In STM imaging, the tip is located at a fraction
of a nanometer above the surface (green tracking line). The
current between the W-probe and Au surface is the feedback
signal and very localized, and as such, the lateral dimension
of the features (e.g., dendrimers) underneath are clearly
deﬁned from topographic images. The height in the STM
topograph is inﬂuenced by the local structure as well as
local density of states (LDOS). Although the STM height,
referred to as apparent height (hAPP), is a sensitive indicator
of surface features, the accuracy is diﬃcult to gauge due
to the diﬃculties in determining the LDOS contribution.
Therefore, AFM is frequently utilized for the same sample
to determine the height of dendrimers [28]. As illustrated in
Scheme 3,thetrueheightofthePAMAMdendrimers ismea-
sured from the Au substrate to the apex of the dendrimer. For
the cleanness ofthe Ausubstrate, nanoshaving is exercised to
remove adsorbates from the deﬁned area to expose the Au as
a reference of the origin [28] .O u rp r e v i o u ss t u d i e sh a v ec o r -
related thehAPP andtrueheightwiththiscombinedapproach
[28, 29].
3.5. Uploading of Indomethacin Results in Increased Integrity
and Size of PAMAM Dendrimers. Figure 2 shows STM
images of dendrimers on surfaces. Upon immobilization,
dendrimers deform and adopt elliptical cap geometry. Upon
uptake of indomethacin, STM imaging reveals that G4
PAMAM-OH-(Pt2+)n-(Indo)m dendrimers are taller than
the bare G4 dendrimers. Figure 2(a) is a 20 × 20nm2 STM
topograph of G4 PAMAM-OH-(Pt2+)n-(Indo)m dendrimers
immobilized on a Au(111) surface. The bright protrusions
correspond to individual G4 PAMAM-OH-(Pt2+)n-(Indo)m
dendrimer molecules. The STM apparent height, or hAPP,
is obtained by measuring the height from the lowest point
in the immediate surrounding matrix to the top of the
dendrimer. These cursors indicate that dendrimers loaded
with indomethacin adopt an elliptical dome shape similar
to the base dendrimers reported previously [28, 29, 47, 48].
The hAPP in cursor proﬁles 1 and 2 is 0.43 and 0.48nm,8 Journal of Drug Delivery
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Scheme 3: Method of measuring the volume of PAMAM dendrimers using STM and AFM. The hAPP and lateral dimensions of single
dendrimers are obtained through STM topographs (a). The removal of surface adsorbates under high force (b) allows for AFM height
measurements during subsequent scans under normal imaging load (c).
respectively. In contrast, the hAPP of a typical G4 dendrimer,
as shown in Figure 2(a), measures 0.35nm and 0.33nm,
respectively. The uptake of indomethacin increases the hAPP
by 0.08nm. Among the 102 dendrimers we compared,
drug-loaded G4 dendrimers appear 0.09 ± 0.02nm taller
than the dendrimers themselves. The true height is further
investigated using AFMas described in theprevioussec-tion.
The typical real height (hREAL) for G4 and indo-G4 com-
plexes are 2.5 ± 0.3nm and 3.4 ± 0.7nm, respectively.
After measuring the lateral and vertical dimensions, the
volume of dendrimers can be accurately determined and
compared. Assuming an elliptical cap geometry for all dend-
rimers,thevolumeofindividualmoleculesmaybecalculated
using V = (1/6πhREAL)(3/4ab + hREAL
2), where a and b are
the long and short lateral axes, respectively. In a typical case
shown in Figure 2, the lateral dimensions are a = 5.6nm,
b = 4.2nm for the indomethacin-loaded G4 and the height
is 3.4nm, thus V = 52.3nm 3.F r o mF i g u r e2(b), the bare
G4 dendrimers measure a = 5.7nm, b = 5.2nm, and
hREAL = 2.2nm, which corresponds to a V = 31.2nm 3.
Among the 102 dendrimers compared, drug-loaded
dendrimers are 54% more voluminous than base dend-
rimers. The average lateral dimensions are a = 6.8 ± 1.2nm
and b = 5.6 ± 0.9nm for indomethacin-loaded G4
and a = 6.2±0.8nmandb = 5.1±0.7nm for unloaded G4.
Since the lateral deformation of both loaded and unloaded
G4 dendrimers are similar, the height, and thus volume,
increases observed with the addition of indomethacin
suggest that the addition of indomethacin to the exterior of
dendrimers increases the overall structural integrity upon
surface immobilization.
3.6. STM Imaging Enables Visualization of Individual Indo-
methacin Molecules Carried by Dendrimers. The indo-
methacin is distinctly recognizable in STM topographs, be-
cause they appear taller and usually broader than the −OH
termini ofdendrimers. Figure 3illustrates how todistinguish
the two types of features. Since Figures 3(a) and 3(b) display
with the same STM apparent height range, the contrast
indicates the height and enables a directly comparison.
It is clearly seen that the ﬁne features at the surface of
G4 PAMAM-OH-(Pt2+)n-(Indo)m dendrimers (Figure 3(a))Journal of Drug Delivery 9
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Figure 2: STM and AFM topographic lateral and height measurements determine the volume of single G4 PAMAM-OH-(Pt
2+)n-(Indo)m
andG4 PAMAM-OH-(Pt
2+)n dendrimers. (a)A 20 ×20nm2 STMtopographofG4PAMAM-OH-(Pt
2+)n-(Indo)m dendrimers immobilized
on Au(111). Cursors 1 and 2 reﬂect the hAPP and lateral measurements. (b) A 20 × 20nm2 STM topograph of G4 PAMAM-OH-(Pt
2+)n
dendrimers immobilized on Au(111). Cursors 4 and 5 reﬂect the STM height and lateral measures. STM images (a) and (b) were obtained
using circa 0.3V and 20pA set points. (c) A 300 × 300nm2 AFM topograph of the same surface as (a). Cursor 3 is a representative of the
cursors used to ascertain hREAL f r o mt h eb a r eA us u r f a c et ot h ed e n d r i m e ra p e x .( d )A3 0 0× 300nm2 AFM topograph of the samesurface as
(b). Cursor 6 serves the same purpose for G4 PAMAM-OH-(Pt
2+)n as cursor 3 does for drug-loaded dendrimers.10 Journal of Drug Delivery
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Figure 3: Visualization of indomethacin features from high-resolution STM images. (a) A 40 × 40nm2 STM topographic image of G4
PAMAM-OH-(Pt
2+)n-(Indo)m dendrimers immobilized on Au(111). The inset in (a) is a 5 × 5nm 2 high-resolution image of a single drug-
loaded dendrimer from the samesurface showingindomethacinfeatures (red arrows) and a dendrimer intramolecularfeature (blue arrow).
(b) A 40 × 40nm2 STM topographic image of G4 PAMAM-OH-(Pt
2+)n dendrimers immobilized on Au(111). The 6 × 6nm 2 inset is a bare
dendrimer, where only intramolecular features are visible (blue arrows). All STM images were acquired at 0.3V and 20pA. The color scale
is normalized to reﬂect the apparent height range of 0.00–0.85nm.
appear brighter than the unloaded dendrimers which have
only −OH at the termini (Figure 3(b)). Figure 3(a) is a STM
topographic image of a G4 PAMAM-OH-(Pt2+)n-(Indo)m
dendrimersurface and the inset is a high-resolution image of
a single dendrimer in which the intramolecular features are
clearly visible. At ﬁrst glance, these intramolecular features
fall into two types of contrast; that is, one appears brighter
than the other. Both previous and present studies of G4-
dendrimer reveal the apparent height of −OH termini to
be below 0.11nm [28, 29]. Therefore, we conclude that the
bright and tall features identiﬁed in Figure 3(a) are new
entities, that is, due to attachment by indomethacin. Among
20 G4 PAMAM-OH-(Pt2+)n-(Indo)m dendrimers analyzed,
indomethacin features have a hAPP range = 0.12–0.25nm
with an average hAPP = 0.16nm. In contrast, intramolec-
ular feature hAPP measured on indomethacin-loaded and
unloaded metal ion-doped G4 PAMAM-OH dendrimers
ranged 0.03–0.10nm, among 40 dendrimers measured pre-
viously[28]andinthisstudy.Usingthethresholdof0.12nm,
we were able to assign intramolecular and indomethacin
features in the STM images, therefore, to count how many
indomethacin each dendrimer could carry. Among all 19
intramolecular protrusions visible in Figure 3(a),1 3f a l l
under 0.12nm (0.03 to 0.11nm), and 6 are above 0.12nm
(0.13 to 0.17nm), thus assignment of 13 termini and 6
indomethacin molecules. Figure 3(b) is an STM topographic
image of a base dendrimer molecule, G4 PAMAM-OH-
(Pt2+)n, where intramolecular features, or −OH termini, are
clearly visible [28]. The number of indomethacin molecules
carried byG4PAMAM-OH variesfrom2 to14among the20
typical dendrimers analyzed in this investigation. This range
is consistent with a previous report where each G4 PAMAM-
OHdendrimermoleculecouldhold 12.5indomethacin[11].
It is possible that indomethacin may reside in the dendrimer
interior void space; therefore, the observed number of
indomethacin per dendrimer most likely represents the
minimum uptake. Our investigations also reveal that the
drug carrying capacity (load) increases with the generation,
for example, G3, G4, and G5 PAMAM-OH-(Pt2+)n-(Indo)m
dendrimers carry 5–7, 2–14, and 2–19 drugs, respectively
[29]. The variations in height and geometry of dendrimer-
immobilized indomethacin molecules suggest that drugs are
nonspeciﬁcally bound to thedendrimer termini and exposed
amidoamine moieties.
4.Conclusions
This study demonstrates the signiﬁcance of using STM
and AFM in the fundamental studies of new drug-delivery
vehicles, telodendrimer micelles and PAMAM dendrimers.
The preliminary results indicate that the exquisitely high-
resolution images enable insightful and fundamental infor-
mation be revealed in the context of molecular level location
and load of drug molecules, as well as the stability of drug-
carrier complex. The number of drug molecules per carrier
can be directly extracted in the case of dendrimers and
estimated in the case of telodendrimer micelles. Since those
studies are at the individual carrier’s level, the results can
be directly linked to simulations which shall facilitate the
prediction and design of new carriers.
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